Sinusoidal Obstruction Syndrome Following Liver Transplantation: Potential Implication of Mycophenolate Mofetil [0.03%]
肝移植后的窦性阻塞性综合征：吗替麦考酚酯的潜在作用
Mukul Vij,Dinesh Jothimani,Komalavalli Subbiah et al.
Mukul Vij et al.
Sinusoidal Obstruction Syndrome Following Liver Transplantation: Potential Implication of Mycophenolate Mofetil [0.03%]
肝移植后的窦性阻塞综合征：霉酚酸酯的潜在作用
Mukul Vij,Dinesh Jothimani,Komalavalli Subbiah et al.
Mukul Vij et al.
Management Strategies and Clinical Outcomes in Steroid-resistant Rejection after Liver Transplantation: A Systematic Review and Meta-analysis [0.03%]
肝移植后糖皮质激素抵抗性排斥反应的管理策略及临床预后的系统评价和 meta 分析
V U Lakshmi,Dinesh Balakrishnan,M P Narmadha et al.
V U Lakshmi et al.
Objectives: To synthesize the available evidence on management strategies and associated clinical outcomes of steroid-resistant rejection (SRR) following liver transplantation. ...
Digital Pathology-Enabled Artificial Intelligence for Fibrosis Assessment in Metabolic Dysfunction-Associated Steatohepatitis: Needs, Current Progress, and Barriers [0.03%]
代谢紊乱相关脂肪肝炎纤维化评估的数字病理学驱动人工智能：需求、当前进展和障碍
Archana Rastogi
Archana Rastogi
Metabolic dysfunction-associated steatotic liver disease (MASLD) is emerging as the most common chronic liver disorder worldwide. However, most of the candidate drugs, except resmetirom, have failed in the metabolic dysfunction-associated s...
Phenotype-Stratified Outcomes and the Role of Early Extracorporeal Support in Hepatitis A-Related Acute Liver Failure: Experience from a Tertiary Care Centre [0.03%]
基于表型的预后及早期内外膜支持在甲型肝炎相关急性肝功能衰竭中的作用：一家三级医疗中心的经验
Ramit Mahajan,Rubina K Mahajan,Ajit Sood et al.
Ramit Mahajan et al.
Breaking Barriers in Hepatocellular Carcinoma: Synergistic Potential of Stereotactic Body Radiotherapy Combined With Immunotherapy [0.03%]
肝细胞癌的治疗壁垒：立体定向体放射与免疫治疗联合应用的协同作用力
Deepti Sharma,Babu Lal Meena,Divya Khosla
Deepti Sharma
Background: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, with limited long-term survival for patients presenting with advanced or unresectable disease. While immune checkpo...
Outcomes of Pediatric ABO-Incompatible Living Donor Liver Transplantation: A Retrospective Single-Centre Experience from India [0.03%]
印度儿科ABO不合活体肝移植的回顾性单中心经验及其结局研究
Jagadeesh Menon,Prithviraj Nabi,Deepti Sachan et al.
Jagadeesh Menon et al.
Background/aims: ABO incompatible liver transplant (ABOi-LT) is an essential alternative to blood-group-compatible liver transplant (LT) in children, and there is limited experience with this, especially from the developi...
Predicting Recompensation in Alcohol, HBV and HCV-associated Decompensated Cirrhosis [0.03%]
酒精、乙肝和丙肝相关失代偿期肝硬化的复发预测模型
Umang Arora,Ritik Goyal,Ishan Gupta et al.
Umang Arora et al.
Background: Recompensation of cirrhosis represents sustained clinical improvement in decompensated cirrhosis following effective etiological treatment. Baseline predictors can help prognostication in hepatology practice. ...
Nephropathy Following Portosystemic Shunt Surgery in Children With Extrahepatic Portal Venous Obstruction: An Unusual Complication [0.03%]
门体静脉畸形分离症术后儿童并发肾病一例罕见并发症
Akash Nair,Moinak Sen Sarma,Ankur Mandelia et al.
Akash Nair et al.
Background/aims: Portosystemic shunt (PSS) surgery is a well-established procedure for managing portal hypertension and associated complications of extrahepatic portal venous obstruction (EHPVO) in children. However, the ...
Aathira Ravindranath,Rajkumar P Wadhwa
Aathira Ravindranath